'Corrigendum to Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty liver disease [Contemp Clin Trials 37 (2) (2014) 301-311]'

Contemporary Clinical Trials

Volumn 38, Issue 1, 2014, Pages 156-

  Scorletti, E ^a   Bhatia, L ^a,b   McCormick, K G ^a   Clough, G F ^a   Nash, K ^c   Calder, P C ^a,b   Byrne, C D ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR;

EID: 84900439467     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2014.04.004     Document Type: Erratum

References (1)

1. Parker H.M., Johnson N.A., Burdon C.A., Cohn J.S., O'Connor H.T., George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012, 56(4):944-951.